Abner Herrman & Brock LLC Biogen Inc. Transaction History

Abner Herrman & Brock LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 12, 2021	SELL	$236.26 - $355.63 $3.05 Million - $4.6 Million	-12,921 Closed	0 $0
Q3 2020 Oct 08, 2020	BUY	$264.77 - $305.71 $1.16 Million - $1.35 Million	4,400 Added 51.64%	12,921 $3.67 Million
Q2 2020 Jul 10, 2020	BUY	$258.66 - $342.55 $105,791 - $140,102	409 Added 5.04%	8,521 $2.28 Million
Q1 2020 Apr 09, 2020	BUY	$268.85 - $341.04 $29,573 - $37,514	110 Added 1.37%	8,112 $2.57 Million
Q4 2019 Jan 10, 2020	BUY	$220.06 - $304.07 $1.76 Million - $2.43 Million	8,002 New	8,002 $2.37 Million

1,015

126M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.3B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Abner Herrman & Brock LLC, based on Form 13F filings with the SEC.

Stay updated on Abner Herrman & Brock LLC with notifications on news.